Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.

Plant BJ, Einarsson GG, Deasy KF, Dahly D, Singh PK, Barry PJ, Goss CH, Fajac I, Vagg T, Durieu I, Flanagan E, O'Callaghan G, Martin C, Burgel PR, Haworth CS, Floto RA, Downey DG, Dupont LJ, Jones AM, Elborn JS, Eustace JA, Mall MA, Tunney MM

Open source

DOI: 10.1183/13993003.02443-2024
Published: 2025 Aug
Container: The European respiratory journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/13993003.02443-2024,
  title = {Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.},
  author = {Plant BJ and Einarsson GG and Deasy KF and Dahly D and Singh PK and Barry PJ and Goss CH and Fajac I and Vagg T and Durieu I and Flanagan E and O'Callaghan G and Martin C and Burgel PR and Haworth CS and Floto RA and Downey DG and Dupont LJ and Jones AM and Elborn JS and Eustace JA and Mall MA and Tunney MM},
  year = {2025},
  journal = {The European respiratory journal},
  doi = {10.1183/13993003.02443-2024},
  url = {https://doi.org/10.1183/13993003.02443-2024}
}

RIS

TY  - JOUR
TI  - Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.
AU  - Plant BJ
AU  - Einarsson GG
AU  - Deasy KF
AU  - Dahly D
AU  - Singh PK
AU  - Barry PJ
AU  - Goss CH
AU  - Fajac I
AU  - Vagg T
AU  - Durieu I
AU  - Flanagan E
AU  - O'Callaghan G
AU  - Martin C
AU  - Burgel PR
AU  - Haworth CS
AU  - Floto RA
AU  - Downey DG
AU  - Dupont LJ
AU  - Jones AM
AU  - Elborn JS
AU  - Eustace JA
AU  - Mall MA
AU  - Tunney MM
PY  - 2025
JO  - The European respiratory journal
DO  - 10.1183/13993003.02443-2024
UR  - https://doi.org/10.1183/13993003.02443-2024
ER  -

APA

BJ, P., GG, E., KF, D., D, D., PK, S., PJ, B., CH, G., I, F., T, V., I, D., E, F., G, O., C, M., PR, B., CS, H., RA, F., DG, D., LJ, D., AM, J., JS, E., JA, E., MA, M., & MM, T. (2025). Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.. The European respiratory journal. https://doi.org/10.1183/13993003.02443-2024

Source records

pubmed · retrieved 2026-09-25T13:13:38.394Z